Cermin Dunia Kedokteran
Vol 46 No 10 (2019): Farmakologi - Continuing Professional Development

Rifampisin Ofloksasin Minosiklin (ROM) sebagai Terapi Alternatif Morbus Hansen

Riza Deviana (Klinik UKP Imam Bukhari, Gondangrejo, Karanganyar, Indonesia)

Article Info

Publish Date
01 Oct 2019

Abstract

Morbus Hansen merupakan penyakit infeksi yang masih terus muncul. Multi-drug therapy (MDT) dari WHO banyak bermanfaat, namun masih belum bisa mengeradikasi penyakit ini. Kombinasi Rifampisin-Ofloksasin-Minosiklin memiliki efek anti-kusta yang menjanjikan dan mungkin dapat digunakan sebagai terapi alternatif Morbus Hansen. Morbus Hansen is an infectious disease that is still a problem. MDT from WHO have been very useful, but still can’t eradicate leprosy. A combination therapy of Rifampicin-Ofloxacin-Minocyclin appeared to be promising and can be used as an alternative therapy.

Copyrights © 2019




Citation Download
RIS
EndNote, Reference Manager, ProCite
BibTex
Latex, Jabref
Original Source
Download Original
Google Scholar
Check in Google Scholar
Journal Info
Cermin Dunia Kedokteran
Website

Abbrev

cdk

Publisher

PT. Kalbe Farma Tbk.

Subject

Health Professions

Description

Cermin Dunia Kedokteran (CDK) is a Medical Journal published since 1974 and affiliated with PT Kalbe Farma Tbk. CDK is intended to help accommodate scientific publications and help increase and disseminate knowledge related to the development of medical science, pharmacy, and public health. CDK ...